<DOC>
	<DOCNO>NCT00795522</DOCNO>
	<brief_summary>This open-label study conduct determine effect DL treatment CIU symptom disease severity , quality life , daytime functioning , quality sleep .</brief_summary>
	<brief_title>An Open-Label Study Effects Desloratadine ( Aerius . ) Treatment Quality Life Patients With Chronic Idiopathic Urticaria ( Study P02540 )</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>Subjects must demonstrate willingness participate study comply procedure sign write informed consent . Subjects must &gt; = 18 year age , either sex race . Women childbearing potential ( include woman less 1 year postmenopausal woman become sexually active ) must use acceptable method birth control ( e.g. , hormonal contraceptive , medically prescribe IUD , condom combination spermicide ) surgically sterilize ( e.g. , hysterectomy tubal ligation ) . Women childbearing potential counseled appropriate use birth control study . Women currently sexually active must agree consent use one abovementioned method become sexually active participate study . Subjects must general good health ; i.e. , must free clinically significant disease ( CIU ) would interfere study evaluation . Subjects must understand able adhere dose visit schedule , agree complete questionnaire record symptom severity score , medication time , concomitant medication , adverse event accurately consistently daily diary . Subjects must least 6week history CIU ( pruritus hive ) prior Visit 1 ( Screening ) . Subjects must pruritus score &gt; = 2 hive score &gt; = 1 Visit 1 . Subjects must experience current CIU flare least 3 week duration , hive present least 3 day per week , prior Visit 1 ( Screening ) . Subjects must score overall condition CIU &gt; = 2 Visit 1 ( Screening ) Visit 2 ( Baseline ) . Subjects must total pruritus score &gt; = 14 sum morning evening ( reflective ) diary score 3 day prior Visit 2 ( Baseline ) plus morning score day Visit 2 . Women childbearing potential must negative urine pregnancy test Visit 2 ( Baseline ) . Women pregnant nursing . Subjects observed designate washout period prohibit medication outline . Subjects asthma require chronic use inhale systemic corticosteroid . Subjects drug food allergy manifest skin reaction . Subjects urticaria primarily due physical urticaria know etiology . Subjects CIU unresponsive antihistamine . Subjects hospitalize ( include emergency department visit ) deterioration CIU within 3 month prior Visit 1 ( Screening ) . Subjects history hypersensitivity desloratadine excipients . Subjects previously randomize study . Subjects staff personnel directly involve administration study . Subjects clinically significant metabolic , cardiovascular , immunologic , neurologic , hematologic , gastrointestinal , cerebrovascular , respiratory disease , disorder , judgment Investigator , may interfere study evaluation affect subject safety . Subjects history psychosis , antagonistic personality , poor motivation , hypochondriasis , emotional intellectual problem likely limit validity consent participate study . Subjects history noncompliance medication treatment protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>